Ultrasound could replace colonoscopies for Crohn's patients on new drug
NCT ID NCT07308067
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how quickly risankizumab (Skyrizi) heals deep intestinal damage in people with Crohn's disease. Instead of repeated colonoscopies, researchers use intestinal ultrasound to track healing at 4 and 12 weeks. The goal is to find a simpler, more comfortable way to monitor treatment success. About 109 adults with Crohn's disease who are starting risankizumab will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amiens university hospital
Amiens, France
-
Clermont-Ferrand University hospital
Clermont-Ferrand, France
-
Grenoble university hospital
Grenoble, France
-
Marseille University Hospital
Marseille, France